Li Min, Shi Yuehui, Sun Lina, Liu Lin, Qu Chen, Zou Jun
Department of Ophthalmology, Shanghai Tenth People's Hospital, No. 301 Middle Yanchang Road, Shanghai 200072, China.
J Ophthalmol. 2019 Apr 1;2019:6936042. doi: 10.1155/2019/6936042. eCollection 2019.
To compare the effects of correcting high myopia using the MEL®90 Triple-A profile LASEK at a 500 Hz pulse rate (Triple-A group) versus the Zyoptix tissue-saving ablations of Technolas 217z laser platform at 100 Hz (TS group).
This retrospective study included 50 eyes in the Triple-A group and 42 eyes in the TS group with manifest refraction spherical equivalent (MRSE) of -6 diopters (D) to -10 D. We compared uncorrected distance visual acuity, MRSE, corrected distance visual acuity, and postoperative complications at 1 month, 3 months, and 6 months.
At 6 months after refractive surgery, the efficacy index of Triple-A group was significantly higher than that of the TS group (1.03 ± 0.12 vs 1.00 ± 0.11, =0.04). The MRSE postoperatively in the Triple-A group was significantly lower than that in the TS group (0.25 ± 0.18 vs 0.38 ± 0.23, < 0.01). The safety indices in the two groups were almost the same after 6 months of surgery (1.03 ± 0.07 vs 1.04 ± 0.11, =0.63). The proportion of eyes which achieved ±0.13 D was significantly higher in the Triple-A group than that in the TS group at 1 month (80% vs 59.5%, =0.03), 3 months (82% vs 61.9%, =0.03) and 6 months (84% vs 64.3%, =0.03). The changes in refraction 6 months after surgery comparing with 1 month after surgery were 0.12 ± 0.10 D in the Triple-A group and 0.13 ± 0.08 D in the TS group (=0.56). All (100%) of the patients in the Triple-A group and 50% of the patients in the TS group had a UDVA of 20/16 at 6 months after surgery ( < 0.01). The induced spherical aberrations and total HOAs in the Triple-A group were significantly lower than those in the TS group (0.17 ± 0.02 m vs 0.23 ± 0.02 m, < 0.01; 0.20 ± 0.04 m vs 0.39 ± 0.03 m, < 0.01) at 6 months after surgery. The mean reduced corneal thickness was 113.06 ± 10.5 m in the Triple-A profile group and 121.43 ± 23.46 m in the TS group (=0.02). No patient in either group had haze and high intraocular pressure 6 months after surgery.
For treatment of high-myopia patients, the Triple-A profile was more effective, predictable, and accurate than the Zyoptix tissue-saving profile. Meanwhile, the Triple-A profile had less induced spherical aberrations, total HOAs, and cornea ablation depth than the Zyoptix tissue-saving profile. Patients in the Triple-A group with 500 Hz pulse rate treatment achieved superior results. The two surgical procedures were equivalent in terms of safety and stability.
比较采用500Hz脉冲频率的MEL®90 Triple - A型准分子原位角膜磨镶术(LASEK)(Triple - A组)与采用100Hz的Technolas 217z激光平台的Zyoptix节省组织消融术(TS组)矫正高度近视的效果。
这项回顾性研究纳入了Triple - A组的50只眼和TS组的42只眼,其明显验光球镜等效值(MRSE)为-6屈光度(D)至-10D。我们比较了未矫正远视力、MRSE、矫正远视力以及术后1个月、3个月和6个月时的并发症。
屈光手术后6个月,Triple - A组的疗效指数显著高于TS组(1.03±0.12对1.00±0.11,P = 0.04)。Triple - A组术后的MRSE显著低于TS组(0.25±0.18对0.38±0.23,P < 0.01)。手术6个月后两组的安全指数几乎相同(1.03±0.07对1.04±0.11,P = 0.63)。在1个月(80%对59.5%,P = 0.03)、3个月(82%对61.9%,P = 0.03)和6个月(84%对64.3%,P = 0.03)时,Triple - A组达到±0.13D的眼比例显著高于TS组。与术后1个月相比,手术6个月后Triple - A组的屈光变化为0.12±0.10D,TS组为0.13±0.08D(P = 0.56)。手术6个月后,Triple - A组所有(100%)患者和TS组50%的患者的最佳矫正视力(UDVA)为20/16(P < 0.01)。手术6个月后,Triple - A组诱导的球差和总高阶像差显著低于TS组(0.17±0.02μm对0.23±0.02μm,P < 0.01;0.20±0.04μm对0.39±0.03μm,P < 0.01)。Triple - A型组平均角膜厚度减少113.06±10.5μm,TS组为121.43±23.46μm(P = 0.02)。两组患者术后6个月均未出现 haze和高眼压。
对于高度近视患者的治疗,Triple - A型比Zyoptix节省组织型更有效、可预测且准确。同时,Triple - A型比Zyoptix节省组织型诱导的球差、总高阶像差和角膜消融深度更小。采用500Hz脉冲频率治疗的Triple - A组患者取得了更好的结果。两种手术在安全性和稳定性方面相当。